Administration - Resource for Molecular Imaging Agents in Precision Medicine
管理 - 精准医学中分子成像剂的资源
基本信息
- 批准号:10226207
- 负责人:
- 金额:$ 7.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAdvocateAnimal Care and Use CommitteesAnimalsAppointmentBasic ScienceBiologicalClinical MedicineClinical ResearchCollaborationsComprehensive Cancer CenterDevelopmentDiscipline of Nuclear MedicineEngineeringEnvironmentExtramural ActivitiesFinancial ActivityFinancial SupportFundingGuidelinesHumanImmunityImmunologyInflammationInstitutesInstitutionInstitutional Review BoardsInternationalMaintenanceMalignant NeoplasmsMedicalMethodsModalityMonitorNational Institute of Biomedical Imaging and BioengineeringPatientsProductivityProgress ReportsProtocols documentationRadiology SpecialtyRadiopharmaceuticalsResearchResearch PersonnelResourcesRunningSchoolsServicesTrainingUnited States National Institutes of HealthValidationWorkcohesionexperienceimaging agentmedical schoolsmeetingsmembermolecular imagingnuclear divisionoperationorganizational structureprecision medicineprogramsscientific organization
项目摘要
BTRC ADMINISTRATION and MANAGEMENT
SUMMARY
The Administrative Core of the Resource for Molecular Imaging Agents in Precision Medicine will coordinate all
activities of the BTRC including provision of a liaison to the Collaborative and Service Projects to assure their
sustained productivity. This Core will be housed within the organizational structure of the Division of Nuclear
Medicine and Molecular Imaging within the Department of Radiology. This Core will also be responsible for
organizing oversight, namely, meetings of the Internal and External Scientific Advisory Committees. In
collaboration with staff in the Training and Dissemination Core It will be the focal point for organization of scientific
meetings and retreats related to the TR&Ds in a continual effort to maintain their cohesion and sense of purpose.
The PI of this Core, Dr. Pomper, is experienced in the synthesis and development of molecular imaging agents
for a variety of modalities and is conversant in both basic research and clinical medicine, particularly radiology
and nuclear medicine. He has substantial experience in running NIH-funded programs in parallel and in
collaboration with investigators external to Johns Hopkins. Dr. Pomper will be responsible for routine operation
of this Core in close collaboration with the PIs of the four TR&Ds, which will form an Executive Committee of the
BTRC. The PIs of the TR&Ds work in close proximity on the Broadway Campus of Johns Hopkins Medical
Institutions, facilitating face-to-face meetings, which will occur formally on a bi-monthly basis. As these PIs are
already collaborating on other projects, informal meetings will occur much more frequently if not on a daily basis.
The Executive Committee will turn to the IAC and EAC for further input on an annual basis, each, offset by a six
month interval. The IAC and EAC will be comprised of local and extramural experts, respectively, in the synthesis,
characterization, validation and implementation of molecular imaging agents for a variety of modalities. As the
biological theme of the BTRC is relationships between cancer, inflammation and immunity, we will have at least
one IAC and one EAC member dedicated to immunology. In this Core we will also have two consultants, each
of whom is an international leader in immunology. The EAC will also have one member who will serve as a
patient advocate. Minutes of the EAC meetings will be provided in annual progress reports to NIBIB. There are
many other informal aspects of oversight at Johns Hopkins with which the Administrative Core will interface,
including the Radioactive Drug Research Committee, the Animal Care and Use Committee, the Clinical
Research Office of the Sidney Kimmel Comprehensive Cancer Center and the Institutional Review Board. The
Administrative Core will support the TR&Ds in development and maintenance of relevant animal and human
protocols, where appropriate.
Financial aspects of the BTRC will be closely monitored through the Administrative Core. There is strong
institutional support, including financial support, for the BTRC as described by the Dean's office and the Interim
Director of Radiology at Johns Hopkins.
BTRC 行政管理
概括
精准医学分子影像剂资源的管理核心将协调所有
BTRC 的活动,包括为合作和服务项目提供联络,以确保他们的
持续的生产力。该核心将设在核部门的组织结构内
放射科内的医学和分子成像。该核心还将负责
组织监督,即内部和外部科学咨询委员会会议。在
与培训和传播核心工作人员的合作它将成为组织科学活动的焦点
与 TR&D 相关的会议和务虚会,不断努力保持其凝聚力和使命感。
该核心PI Pomper博士在分子显像剂的合成和开发方面拥有丰富的经验
适用于多种模式,熟悉基础研究和临床医学,特别是放射学
和核医学。他在并行和独立运行 NIH 资助的项目方面拥有丰富的经验。
与约翰霍普金斯大学外部的研究人员合作。 Pomper博士将负责日常操作
该核心与四个 TR&D 的 PI 密切合作,这将组成一个执行委员会
BTRC。 TR&D 的 PI 在约翰·霍普金斯医学院百老汇校区附近工作
机构,促进面对面会议,该会议将每两个月正式举行一次。由于这些 PI 是
由于已经在其他项目上进行了合作,非正式会议即使不是每天举行,也会更加频繁地举行。
执行委员会将每年向 IAC 和 EAC 寻求进一步的意见,各自抵消六次
月间隔。 IAC 和 EAC 将分别由本地和校外专家组成,负责综合、
用于多种模式的分子成像剂的表征、验证和实施。作为
BTRC的生物学主题是癌症、炎症和免疫之间的关系,我们至少会有
一名 IAC 和一名 EAC 成员致力于免疫学。在这个核心中,我们还将有两名顾问,每人
其中免疫学领域的国际领先者。选管会还将有一名成员担任
患者倡导者。 EAC 会议纪要将在向 NIBIB 提交的年度进度报告中提供。有
约翰·霍普金斯大学的许多其他非正式监督方面将与行政核心进行交互,
包括放射性药物研究委员会、动物护理和使用委员会、临床委员会
悉尼金梅尔综合癌症中心研究办公室和机构审查委员会。这
行政核心将支持 TR&D 开发和维护相关动物和人类
协议(如适用)。
BTRC 的财务方面将通过行政核心进行密切监控。有很强的
如院长办公室和临时委员会所述,为 BTRC 提供机构支持,包括财政支持
约翰·霍普金斯大学放射科主任。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTIN G POMPER其他文献
MARTIN G POMPER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTIN G POMPER', 18)}}的其他基金
Translational imaging biomarkers of the tumor microenvironment in early prostate cancer
早期前列腺癌肿瘤微环境的转化成像生物标志物
- 批准号:
10698133 - 财政年份:2022
- 资助金额:
$ 7.79万 - 项目类别:
Translational imaging biomarkers of the tumor microenvironment in early prostate cancer
早期前列腺癌肿瘤微环境的转化成像生物标志物
- 批准号:
10518916 - 财政年份:2022
- 资助金额:
$ 7.79万 - 项目类别:
Resource for Molecular Imaging Agents in Precision Medicine
精准医学分子成像剂资源
- 批准号:
10226206 - 财政年份:2017
- 资助金额:
$ 7.79万 - 项目类别:
Training/Dissemination - Resource for Molecular Imaging Agents in Precision Medicine
培训/传播 - 精准医学分子成像剂资源
- 批准号:
10226214 - 财政年份:2017
- 资助金额:
$ 7.79万 - 项目类别:
Imaging Agents for Inflammatory Components of Malignancy
恶性肿瘤炎症成分的显像剂
- 批准号:
10226210 - 财政年份:2017
- 资助金额:
$ 7.79万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 7.79万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 7.79万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 7.79万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 7.79万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 7.79万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 7.79万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 7.79万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 7.79万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 7.79万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 7.79万 - 项目类别:














{{item.name}}会员




